These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22133829)

  • 1. [Bone and calcium update; bone research update. Osteoclastogenesis and osteoimmunology].
    Nakashima T; Hayashi M; Takayanagi H
    Clin Calcium; 2011 Dec; 21(12):93-102. PubMed ID: 22133829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [RANKL signal and osteoimmunology].
    Nakashima T; Takayanagi H
    Clin Calcium; 2011 Aug; 21(8):1131-40. PubMed ID: 21814017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteoclast biology and osteoimmunology].
    Nakashima T
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):17-25. PubMed ID: 25765685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoimmunology update--from bench to bedside].
    Takayanagi H
    Nihon Rinsho; 2009 May; 67(5):1031-7. PubMed ID: 19432129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamic interplay between osteoclasts and the immune system.
    Nakashima T; Takayanagi H
    Arch Biochem Biophys; 2008 May; 473(2):166-71. PubMed ID: 18410741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New regulation mechanisms of osteoclast differentiation.
    Nakashima T; Takayanagi H
    Ann N Y Acad Sci; 2011 Dec; 1240():E13-8. PubMed ID: 22360322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclasts, rheumatoid arthritis, and osteoimmunology.
    Sato K; Takayanagi H
    Curr Opin Rheumatol; 2006 Jul; 18(4):419-26. PubMed ID: 16763464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular determinants in osteoclast differentiation and osteoimmunology].
    Takayanagi H
    Rinsho Ketsueki; 2009 Jun; 50(6):447-52. PubMed ID: 19571503
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.
    Takayanagi H
    Nat Rev Immunol; 2007 Apr; 7(4):292-304. PubMed ID: 17380158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteoimmunology: an integrated vision of immune and bone systems].
    Gallois A; Mazzorana M; Vacher J; Jurdic P
    Med Sci (Paris); 2009 Mar; 25(3):259-65. PubMed ID: 19361389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoimmunology.
    Rauner M; Sipos W; Pietschmann P
    Int Arch Allergy Immunol; 2007; 143(1):31-48. PubMed ID: 17191007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between interferon and other cytokine systems in bone metabolism.
    Takayanagi H; Sato K; Takaoka A; Taniguchi T
    Immunol Rev; 2005 Dec; 208():181-93. PubMed ID: 16313349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bone destruction and osteoimmunology.
    Takayanagi H
    J Periodontal Res; 2005 Aug; 40(4):287-93. PubMed ID: 15966905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospects of treatment using interferon for bone diseases].
    Iba K; Takada J; Yamashita T
    Nihon Rinsho; 2006 Jul; 64(7):1275-80. PubMed ID: 16838644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of bone resorption by osteocytes].
    Nakashima T; Hayash M; Takayanagi H
    Clin Calcium; 2012 May; 22(5):685-96. PubMed ID: 22549193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Introduction to osteoimmunology].
    Takayanagi H
    Nihon Rinsho; 2005 Sep; 63(9):1505-9. PubMed ID: 16164203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoimmunology--the hidden immune regulation of bone.
    Caetano-Lopes J; Canhão H; Fonseca JE
    Autoimmun Rev; 2009 Jan; 8(3):250-5. PubMed ID: 18722561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
    Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T
    Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular understanding of osteoclast differentiation.
    Asagiri M; Takayanagi H
    Bone; 2007 Feb; 40(2):251-64. PubMed ID: 17098490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
    Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
    Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.